Allergies 0 9 0 9 O
to 10 12 10 12 O
pig 13 16 13 16 B-allergy_name
- 16 17 16 17 I-allergy_name
derived 17 24 17 24 I-allergy_name
proteins 25 33 25 33 I-allergy_name

Contraindication 0 16 34 50 O
to 17 19 51 53 O
high 20 24 54 58 O
- 24 25 58 59 O
dose 25 29 59 63 O
corticosteroids 30 45 64 79 B-allergy_name
( 46 47 80 81 O
e.g. 47 51 81 85 O
uncontrolled 52 64 86 98 B-chronic_disease
blood 65 70 99 104 I-chronic_disease
sugar 71 76 105 110 I-chronic_disease
) 76 77 110 111 O

Diagnosis 0 9 112 121 O
of 10 12 122 124 O
any 13 16 125 128 O
underlying 17 27 129 139 B-chronic_disease
neurologic 28 38 140 150 I-chronic_disease
disorder 39 47 151 159 I-chronic_disease
that 48 52 160 164 O
would 53 58 165 170 O
potentially 59 70 171 182 O
confound 71 79 183 191 O
interpretation 80 94 192 206 O
of 95 97 207 209 O
the 98 101 210 213 O
study 102 107 214 219 O
results 108 115 220 227 O

Evidence 0 8 228 236 O
of 9 11 237 239 O
current 12 19 240 247 O
serious 20 27 248 255 B-chronic_disease
infection 28 37 256 265 I-chronic_disease
, 37 38 265 266 O
or 39 41 267 269 O
a 42 43 270 271 O
history 44 51 272 279 O
of 52 54 280 282 O
chronic 55 62 283 290 O
or 63 65 291 293 O
recurring 66 75 294 303 O
infections 76 86 304 314 O

History 0 7 315 322 O
of 8 10 323 325 O
malignancy 11 21 326 336 B-cancer

Hydrocephalus 0 13 337 350 B-chronic_disease

Neurologic 0 10 351 361 B-chronic_disease
deficits 11 19 362 370 I-chronic_disease
related 20 27 371 378 O
to 28 30 379 381 O
intraparenchymal 31 47 382 398 B-chronic_disease
brain 48 53 399 404 I-chronic_disease
, 53 54 404 405 O
spinal 55 61 406 412 B-chronic_disease
cord 62 66 413 417 I-chronic_disease
and/or 67 73 418 424 O
cauda 74 79 425 430 B-chronic_disease
equina 80 86 431 437 I-chronic_disease
involvement 87 98 438 449 O

Patient 0 7 450 457 O
with 8 12 458 462 O
sarcoidosis 13 24 463 474 B-chronic_disease
as 25 27 475 477 O
defined 28 35 478 485 O
by 36 38 486 488 O
ATS 39 42 489 492 O
/ 42 43 492 493 O
ERS 43 46 493 496 O
/ 46 47 496 497 O
WASOG 47 52 497 502 O
( 53 54 503 504 O
American 54 62 504 512 O
Thoracic 63 71 513 521 O
Society 72 79 522 529 O
/ 79 80 529 530 O
European 80 88 530 538 O
Thoracic 89 97 539 547 O
Society 98 105 548 555 O
/ 105 106 555 556 O
World 106 111 556 561 O
Association 112 123 562 573 O
for 124 127 574 577 O
Sarcoidosis 128 139 578 589 O
and 140 143 590 593 O
Other 144 149 594 599 O
Granulomatous 150 163 600 613 O
Disorders 164 173 614 623 O
) 173 174 623 624 O

Significant 0 11 625 636 O
change 12 18 637 643 O
in 19 21 644 646 O
corticosteroid 22 36 647 661 O
dose 37 41 662 666 O
within 42 48 667 673 O
the 49 52 674 677 O
past 53 57 678 682 B-upper_bound
4 58 59 683 684 I-upper_bound
weeks 60 65 685 690 I-upper_bound
, 65 66 690 691 O
or 67 69 692 694 O
other 70 75 695 700 O
immunosuppressive 76 93 701 718 B-treatment
medication 94 104 719 729 I-treatment
within 105 111 730 736 O
the 112 115 737 740 O
past 116 120 741 745 B-upper_bound
6 121 122 746 747 I-upper_bound
months 123 129 748 754 I-upper_bound

Stable 0 6 755 761 O
baseline 7 15 762 770 O
immunosuppressive 16 33 771 788 B-treatment
medications 34 45 789 800 I-treatment

